These included: the erythroleukemia cell lines K562C and TF-1C inducible for the expression of siRNA against RPS19 mRNA; the prostate cancer cell line 22Rv1 and the embryonic kidney cell line HEK293 both transiently transfected with siRNA for RPS19. Here, RPS19 is linked to prostate carcinoma.